Alerts
EULAR 2014: Scientific Abstracts
Poster Presentations. Scleroderma, myositis and related syndromes - clinical aspects and treatment
FRI0482 Safety and Tolerability of MEDI-551 in Subjects with Systemic Sclerosis (SSC): Results from A Phase 1 Randomized, Placebo-Controlled Escalating Single-Dose Study